Through additional mechanistic studies, we recently discovered that both TPα and TPβ directly interact with and regulate signalling by protein kinase C-related kinase (PRK) 1 [35], a RhoA effector widely implicated in prostate cancer. This evidence concerns the gene RHOA and prostate carcinoma.